Analysis | Metabolite Name | Measured Value | Units | CASE_CONTROL | Chemotherapy | Drug | Race | TIMEPOINT | Tamoxyfen | Taxane |
---|---|---|---|---|---|---|---|---|---|---|
Reversed phase NEGATIVE ION MODE | ARACHIDONATE (CAS# 506-32-1); (M-H)- | 223542 | Peak area | Case | N | Exemestane | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | ARACHIDONATE (CAS# 506-32-1); (M-H)- | 259871 | Peak area | Control | Y | Exemestane | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | ARACHIDONATE (CAS# 506-32-1); (M-H)- | 267613 | Peak area | Control | N | Exemestane | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | ARACHIDONATE (CAS# 506-32-1); (M-H)- | 270107 | Peak area | Case | N | Letrozole | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | ARACHIDONATE (CAS# 506-32-1); (M-H)- | 289751 | Peak area | Case | Y | Letrozole | White | 3 Month | Y | Y |
Reversed phase NEGATIVE ION MODE | ARACHIDONATE (CAS# 506-32-1); (M-H)- | 303660 | Peak area | Case | N | Letrozole | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | ARACHIDONATE (CAS# 506-32-1); (M-H)- | 319097 | Peak area | Case | N | Exemestane | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | ARACHIDONATE (CAS# 506-32-1); (M-H)- | 340226 | Peak area | Case | N | Letrozole | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | ARACHIDONATE (CAS# 506-32-1); (M-H)- | 354045 | Peak area | Control | Y | Exemestane | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | ARACHIDONATE (CAS# 506-32-1); (M-H)- | 354831 | Peak area | Control | N | Exemestane | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | ARACHIDONATE (CAS# 506-32-1); (M-H)- | 355104 | Peak area | Case | Y | Exemestane | White | Baseline | Y | Y |
Reversed phase NEGATIVE ION MODE | ARACHIDONATE (CAS# 506-32-1); (M-H)- | 367738 | Peak area | Control | N | Letrozole | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | ARACHIDONATE (CAS# 506-32-1); (M-H)- | 375761 | Peak area | Case | N | Letrozole | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | ARACHIDONATE (CAS# 506-32-1); (M-H)- | 380495 | Peak area | Control | N | Exemestane | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | ARACHIDONATE (CAS# 506-32-1); (M-H)- | 390003 | Peak area | Case | Y | Exemestane | White | 3 Month | N | Y |
Reversed phase NEGATIVE ION MODE | ARACHIDONATE (CAS# 506-32-1); (M-H)- | 401527 | Peak area | Case | Y | Exemestane | White | 3 Month | N | Y |
Reversed phase NEGATIVE ION MODE | ARACHIDONATE (CAS# 506-32-1); (M-H)- | 408177 | Peak area | Case | Y | Exemestane | White | 3 Month | N | Y |
Reversed phase NEGATIVE ION MODE | ARACHIDONATE (CAS# 506-32-1); (M-H)- | 425109 | Peak area | Control | N | Exemestane | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | ARACHIDONATE (CAS# 506-32-1); (M-H)- | 433074 | Peak area | Case | N | Exemestane | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | ARACHIDONATE (CAS# 506-32-1); (M-H)- | 434174 | Peak area | Control | Y | Exemestane | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | ARACHIDONATE (CAS# 506-32-1); (M-H)- | 437599 | Peak area | Case | Y | Letrozole | White | Baseline | Y | Y |
Reversed phase NEGATIVE ION MODE | ARACHIDONATE (CAS# 506-32-1); (M-H)- | 464347 | Peak area | Case | Y | Exemestane | White | Baseline | N | Y |
Reversed phase NEGATIVE ION MODE | ARACHIDONATE (CAS# 506-32-1); (M-H)- | 465758 | Peak area | Control | Y | Exemestane | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | ARACHIDONATE (CAS# 506-32-1); (M-H)- | 466626 | Peak area | Control | Y | Exemestane | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | ARACHIDONATE (CAS# 506-32-1); (M-H)- | 487404 | Peak area | Case | Y | Exemestane | White | 3 Month | N | Y |
Reversed phase NEGATIVE ION MODE | ARACHIDONATE (CAS# 506-32-1); (M-H)- | 487871 | Peak area | Control | Y | Exemestane | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | ARACHIDONATE (CAS# 506-32-1); (M-H)- | 489321 | Peak area | Control | N | Exemestane | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | ARACHIDONATE (CAS# 506-32-1); (M-H)- | 493539 | Peak area | Case | N | Exemestane | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | ARACHIDONATE (CAS# 506-32-1); (M-H)- | 493654 | Peak area | Case | Y | Letrozole | White | Baseline | Y | Y |
Reversed phase NEGATIVE ION MODE | ARACHIDONATE (CAS# 506-32-1); (M-H)- | 498936 | Peak area | Control | N | Exemestane | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | ARACHIDONATE (CAS# 506-32-1); (M-H)- | 507172 | Peak area | Control | Y | Exemestane | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | ARACHIDONATE (CAS# 506-32-1); (M-H)- | 516560 | Peak area | Case | Y | Exemestane | White | Baseline | N | Y |
Reversed phase NEGATIVE ION MODE | ARACHIDONATE (CAS# 506-32-1); (M-H)- | 517988 | Peak area | Case | Y | Exemestane | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | ARACHIDONATE (CAS# 506-32-1); (M-H)- | 526313 | Peak area | Case | N | Exemestane | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | ARACHIDONATE (CAS# 506-32-1); (M-H)- | 529023 | Peak area | Control | Y | Letrozole | White | 3 Month | Y | Y |
Reversed phase NEGATIVE ION MODE | ARACHIDONATE (CAS# 506-32-1); (M-H)- | 532044 | Peak area | Case | Y | Exemestane | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | ARACHIDONATE (CAS# 506-32-1); (M-H)- | 533273 | Peak area | Case | N | Exemestane | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | ARACHIDONATE (CAS# 506-32-1); (M-H)- | 539333 | Peak area | Control | N | Letrozole | Black | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | ARACHIDONATE (CAS# 506-32-1); (M-H)- | 541396 | Peak area | Case | Y | Exemestane | White | 3 Month | Y | Y |
Reversed phase NEGATIVE ION MODE | ARACHIDONATE (CAS# 506-32-1); (M-H)- | 548980 | Peak area | Case | N | Exemestane | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | ARACHIDONATE (CAS# 506-32-1); (M-H)- | 559180 | Peak area | Control | N | Letrozole | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | ARACHIDONATE (CAS# 506-32-1); (M-H)- | 560866 | Peak area | Control | Y | Exemestane | White | 3 Month | N | Y |
Reversed phase NEGATIVE ION MODE | ARACHIDONATE (CAS# 506-32-1); (M-H)- | 565767 | Peak area | Control | N | Letrozole | Black | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | ARACHIDONATE (CAS# 506-32-1); (M-H)- | 572917 | Peak area | Case | Y | Letrozole | White | Baseline | Y | Y |
Reversed phase NEGATIVE ION MODE | ARACHIDONATE (CAS# 506-32-1); (M-H)- | 574371 | Peak area | Control | N | Exemestane | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | ARACHIDONATE (CAS# 506-32-1); (M-H)- | 581782 | Peak area | Case | Y | Exemestane | Black | Baseline | N | Y |
Reversed phase NEGATIVE ION MODE | ARACHIDONATE (CAS# 506-32-1); (M-H)- | 589101 | Peak area | Control | Y | Exemestane | White | Baseline | N | Y |
Reversed phase NEGATIVE ION MODE | ARACHIDONATE (CAS# 506-32-1); (M-H)- | 590153 | Peak area | Control | Y | Letrozole | White | Baseline | Y | Y |
Reversed phase NEGATIVE ION MODE | ARACHIDONATE (CAS# 506-32-1); (M-H)- | 596770 | Peak area | Control | Y | Exemestane | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | ARACHIDONATE (CAS# 506-32-1); (M-H)- | 602774 | Peak area | Case | N | Exemestane | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | ARACHIDONATE (CAS# 506-32-1); (M-H)- | 606239 | Peak area | Case | N | Exemestane | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | ARACHIDONATE (CAS# 506-32-1); (M-H)- | 606770 | Peak area | Control | N | Exemestane | Black | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | ARACHIDONATE (CAS# 506-32-1); (M-H)- | 620841 | Peak area | Case | Y | Exemestane | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | ARACHIDONATE (CAS# 506-32-1); (M-H)- | 625711 | Peak area | Control | N | Exemestane | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | ARACHIDONATE (CAS# 506-32-1); (M-H)- | 631209 | Peak area | Control | Y | Exemestane | White | Baseline | N | Y |
Reversed phase NEGATIVE ION MODE | ARACHIDONATE (CAS# 506-32-1); (M-H)- | 631535 | Peak area | Case | Y | Letrozole | White | 3 Month | Y | Y |
Reversed phase NEGATIVE ION MODE | ARACHIDONATE (CAS# 506-32-1); (M-H)- | 635783 | Peak area | Case | Y | Exemestane | White | Baseline | N | Y |
Reversed phase NEGATIVE ION MODE | ARACHIDONATE (CAS# 506-32-1); (M-H)- | 643733 | Peak area | Case | N | Letrozole | Black | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | ARACHIDONATE (CAS# 506-32-1); (M-H)- | 644734 | Peak area | Control | N | Letrozole | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | ARACHIDONATE (CAS# 506-32-1); (M-H)- | 660433 | Peak area | Control | Y | Letrozole | White | 3 Month | Y | Y |
Reversed phase NEGATIVE ION MODE | ARACHIDONATE (CAS# 506-32-1); (M-H)- | 671719 | Peak area | Case | Y | Letrozole | White | 3 Month | Y | Y |
Reversed phase NEGATIVE ION MODE | ARACHIDONATE (CAS# 506-32-1); (M-H)- | 674393 | Peak area | Case | N | Exemestane | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | ARACHIDONATE (CAS# 506-32-1); (M-H)- | 706374 | Peak area | Control | Y | Letrozole | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | ARACHIDONATE (CAS# 506-32-1); (M-H)- | 713089 | Peak area | Case | N | Exemestane | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | ARACHIDONATE (CAS# 506-32-1); (M-H)- | 714435 | Peak area | Control | Y | Letrozole | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | ARACHIDONATE (CAS# 506-32-1); (M-H)- | 714633 | Peak area | Case | N | Letrozole | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | ARACHIDONATE (CAS# 506-32-1); (M-H)- | 716160 | Peak area | Control | N | Exemestane | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | ARACHIDONATE (CAS# 506-32-1); (M-H)- | 720126 | Peak area | Control | N | Exemestane | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | ARACHIDONATE (CAS# 506-32-1); (M-H)- | 723928 | Peak area | Control | N | Exemestane | Black | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | ARACHIDONATE (CAS# 506-32-1); (M-H)- | 732036 | Peak area | Case | N | Exemestane | Black | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | ARACHIDONATE (CAS# 506-32-1); (M-H)- | 735260 | Peak area | Control | N | Letrozole | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | ARACHIDONATE (CAS# 506-32-1); (M-H)- | 751764 | Peak area | Case | N | Letrozole | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | ARACHIDONATE (CAS# 506-32-1); (M-H)- | 757977 | Peak area | Case | N | Letrozole | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | ARACHIDONATE (CAS# 506-32-1); (M-H)- | 759269 | Peak area | Control | N | Letrozole | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | ARACHIDONATE (CAS# 506-32-1); (M-H)- | 764433 | Peak area | Control | N | Exemestane | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | ARACHIDONATE (CAS# 506-32-1); (M-H)- | 770462 | Peak area | Control | N | Letrozole | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | ARACHIDONATE (CAS# 506-32-1); (M-H)- | 771032 | Peak area | Case | Y | Exemestane | White | Baseline | N | Y |
Reversed phase NEGATIVE ION MODE | ARACHIDONATE (CAS# 506-32-1); (M-H)- | 774658 | Peak area | Case | N | Exemestane | Black | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | ARACHIDONATE (CAS# 506-32-1); (M-H)- | 784306 | Peak area | Case | N | Letrozole | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | ARACHIDONATE (CAS# 506-32-1); (M-H)- | 802041 | Peak area | Control | N | Letrozole | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | ARACHIDONATE (CAS# 506-32-1); (M-H)- | 803713 | Peak area | Control | Y | Exemestane | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | ARACHIDONATE (CAS# 506-32-1); (M-H)- | 825349 | Peak area | Case | N | Letrozole | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | ARACHIDONATE (CAS# 506-32-1); (M-H)- | 827149 | Peak area | Case | N | Letrozole | Black | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | ARACHIDONATE (CAS# 506-32-1); (M-H)- | 836542 | Peak area | Control | N | Letrozole | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | ARACHIDONATE (CAS# 506-32-1); (M-H)- | 841472 | Peak area | Control | Y | Exemestane | White | 3 Month | N | Y |
Reversed phase NEGATIVE ION MODE | ARACHIDONATE (CAS# 506-32-1); (M-H)- | 841967 | Peak area | Control | Y | Exemestane | White | 3 Month | Y | Y |
Reversed phase NEGATIVE ION MODE | ARACHIDONATE (CAS# 506-32-1); (M-H)- | 862854 | Peak area | Case | Y | Exemestane | White | Baseline | Y | Y |
Reversed phase NEGATIVE ION MODE | ARACHIDONATE (CAS# 506-32-1); (M-H)- | 868409 | Peak area | Control | N | Letrozole | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | ARACHIDONATE (CAS# 506-32-1); (M-H)- | 878153 | Peak area | Case | Y | Exemestane | Black | 3 Month | N | Y |
Reversed phase NEGATIVE ION MODE | ARACHIDONATE (CAS# 506-32-1); (M-H)- | 880037 | Peak area | Case | N | Exemestane | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | ARACHIDONATE (CAS# 506-32-1); (M-H)- | 882625 | Peak area | Control | N | Exemestane | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | ARACHIDONATE (CAS# 506-32-1); (M-H)- | 893320 | Peak area | Case | N | Letrozole | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | ARACHIDONATE (CAS# 506-32-1); (M-H)- | 896413 | Peak area | Case | Y | Exemestane | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | ARACHIDONATE (CAS# 506-32-1); (M-H)- | 908622 | Peak area | Control | Y | Letrozole | White | Baseline | Y | Y |
Reversed phase NEGATIVE ION MODE | ARACHIDONATE (CAS# 506-32-1); (M-H)- | 909571 | Peak area | Control | N | Letrozole | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | ARACHIDONATE (CAS# 506-32-1); (M-H)- | 925395 | Peak area | Control | Y | Exemestane | White | Baseline | Y | Y |
Reversed phase NEGATIVE ION MODE | ARACHIDONATE (CAS# 506-32-1); (M-H)- | 988316 | Peak area | Control | Y | Exemestane | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | ARACHIDONATE (CAS# 506-32-1); (M-H)- | 1015142 | Peak area | Case | Y | Exemestane | White | 3 Month | Y | Y |
Reversed phase NEGATIVE ION MODE | ARACHIDONATE (CAS# 506-32-1); (M-H)- | 1054356 | Peak area | Control | N | Letrozole | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | ARACHIDONATE (CAS# 506-32-1); (M-H)- | 1103078 | Peak area | Control | N | Letrozole | White | Baseline | Y | N |